Milbemycin Oxime Powder
NDC Package 42513-0010-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Milbemycin Oxime powders is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a powder delivery system. Marketed by Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd., this product is identified by NDC 42513-0010.

Identification & Billing

NDC Package Code
42513-0010-3
Package Description
2 BOTTLE in 1 CARTON / 1 BAG in 1 BOTTLE / 2 kg in 1 BAG
Product Code
42513-0010
11-Digit Billing Format
42513001003

Clinical Specifications

Proprietary Name
Milbemycin Oxime
Non-Proprietary Name
Milbemycin Oxime
Substance Name
Milbemycin Oxime
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
MILBEMYCIN OXIME 1 kg/kg

Regulatory & Marketing

Labeler Name
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
06-01-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (42513-0010). Click a package code to view its specific billing and regulatory data.

42513-0010-1
1 CAN in 1 CARTON / 1 BAG in 1 CAN / 1 BAG in 1 BAG / 2 kg in 1 BAG
42513-0010-2
1 BOTTLE in 1 CARTON / 1 BAG in 1 BOTTLE / 2 kg in 1 BAG

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42513-0010-3 identifies a specific commercial package of 2 bottle in 1 carton / 1 bag in 1 bottle / 2 kg in 1 bag of Milbemycin Oxime (UNFINISHED drug), a bulk ingredient labeled by Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.. This powder is formulated for use and contains milbemycin oxime as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. on June 01, 2016. The current certification is valid through December 31, 2026.

How is this Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42513001003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
42513-0010-3
11-Digit CMS (5-4-2)
42513-0010-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.